Recent advances in polymyalgia rheumatica.

Area of Science:

• Rheumatology
• Immunology
• Medical Imaging

Background:

• Polymyalgia rheumatica (PMR) is a chronic inflammatory condition affecting individuals over 50, presenting with subacute shoulder and pelvic girdle pain and morning stiffness.
• Diagnosis relies on clinical presentation and inflammatory markers due to the absence of a definitive test.
• PMR exhibits heterogeneity, with potential for misdiagnosis (e.g., late-onset rheumatoid arthritis) and a significant comorbidity with giant cell arteritis (16-21% of cases).

Purpose of the Study:

• To provide an updated perspective on the pathogenesis and diagnosis of Polymyalgia Rheumatica.
• To highlight the role of advanced imaging modalities in understanding PMR.
• To explore future treatment strategies informed by key cytokine involvement.

Main Methods:

• Review of current literature on Polymyalgia Rheumatica.
• Focus on diagnostic advancements, including ultrasound and whole-body positron emission tomography/computed tomography (PET/CT).
• Discussion of emerging insights into PMR pathogenesis and cytokine targets.

Main Results:

• Revised classification criteria (2012 EULAR/ACR) aim to define a more homogeneous PMR population for research.
• Advanced imaging, such as ultrasound and PET/CT, offers enhanced insights into PMR pathology.
• Identification of key cytokines involved in PMR pathogenesis is paving the way for targeted therapies.

Conclusions:

• PMR diagnosis remains a clinical challenge, necessitating improved diagnostic tools.
• Imaging modalities are increasingly important for understanding PMR and differentiating it from other conditions.
• Future PMR treatments will likely focus on specific cytokine pathways, offering potential for more effective management.